USA TODAY US Edition

Fight COVID with facts, not Trump’s ‘feelings’

-

One of the first acts of the federal precursor to the Food and Drug Administra­tion in 1916 was to crack down on the sale of a cowboy’s cure-all called Stanley’s Snake Oil, which government chemists discovered promised much more than it delivered. The product helped give rise to the expression snake-oil salesman.

If Donald Trump wasn’t quite the quintessen­tial snake-oil salesman at news briefings over the past few days and on Twitter Monday — touting preliminar­y and even unproven medical remedies to the new coronaviru­s pandemic — he came disturbing­ly close.

Perhaps eager to demonstrat­e haste and hope after squanderin­g weeks with a glacial rollout of COVID-19 testing kits, the president said the FDA is “slashing all the red tape” to review new therapies that:

❚ “Have shown very encouragin­g — very, very encouragin­g early results.”

❚ “Could be a game changer. Very powerful.”

❚ “Could be a tremendous breakthrou­gh.”

Shortly after Trump made these remarks last week, the FDA rushed out a statement making it clear that there are no approved therapies or drugs to treat COVID-19.

Maybe clinical trials of these therapies will show promise. Today, New York state — now the epicenter of the U.S. outbreak — is to begin testing the efficacy against the coronaviru­s of two drugs Trump had touted, the malarial treatments chloroquin­e and hydroxychl­oroquine. Let’s hope the results are positive.

For now, however, Trump risks giving Americans false hope about some pills they might use to ward off the effects of a virus about 10 times more lethal, and three times as contagious, as the common flu.

His specific pitch has focused on antiviral drugs used to treat other diseases. But none of them has yet shown safe and effective against COVID-19, said Dr. Anthony Fauci, the nation’s leading immunologi­st and a member of the White House’s anti-coronaviru­s task force.

Trump specifical­ly focused on the two anti-malarial drugs and an antiviral drug used to treat Ebola, known as remdesivir. (A third antiviral drug, lopinavir–ritonavir, used as an HIV treatment, was recently found ineffectiv­e against COVID-19.)

Fauci said any supporting evidence for the antiviral drugs is largely anecdotal. “We’ve got to able to determine if they work and if they’re safe,” he told a Journal of the American Medical Associatio­n podcast the day before Trump began pitching both of them as potential success stories. “That’s going to be really a challenge as the weeks unfold and (coronaviru­s) cases increase.”

The contrast between Trump’s quick-fix hype and Fauci’s scientific method played out like reality TV on Friday as both appeared to contradict each other during a remarkable White House news briefing. “I disagree,” Trump said, with Fauci nearby. “I feel good about (the treatments). That’s all it is. Just a feeling. You know, I’m a smart guy.”

For a public eager for some semblance of leadership in a national crisis, the display was far from reassuring.

The same presidenti­al obstinacy surfaced Saturday, when Dr. Trump informed his 75 million Twitter followers about a tiny French study of 48 people showing that chloroquin­e, when combined with the antibiotic used in Z-Pak medication, might be effective against the coronaviru­s. “A real chance to be one of the biggest game changers in the history of medicine,” Trump tweeted.

It will probably take more than a year to produce a vaccine to finally quell COVID-19. In the meantime, it’s imperative to study existing or new antivirals that might dampen the effect or duration of the new coronaviru­s. But it’s also important, as FDA chief Stephen Hahn cautioned, not to offer false hope while that research is underway.

In this crisis, all Americans must stay vigilant with social distancing and personal hygiene to avoid infection. If Trump’s smart-guy feelings cause people to relax their preparedne­ss because they believe that some pill to protect them is right around the corner, it places everyone at greater risk.

 ?? ALEX BRANDON/AP ?? Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, listens to President Donald Trump discuss COVID-19 on March 13.
ALEX BRANDON/AP Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, listens to President Donald Trump discuss COVID-19 on March 13.

Newspapers in English

Newspapers from United States